001 Limited are an independent utility specialists with over 20 years of experience in saving money and time for businesses across the UK on energy contracts. They offer a one-stop shop, from procuring energy generated from renewable sources, to validating invoices to ensure suppliers’ billing is correct on a monthly basis.
For more information please visit https://www.001ltd.co.uk/
272BIO Ltd is a specialist biotechnology company which focuses on developing novel biological therapies for veterinary disease areas. 272BIO has an established in vitro laboratory which is based on The Pirbright Institute site, a world-renowned centre of expertise in veterinary disease management and therapy. Biotherapeutics can provide solutions for areas of health which are difficult to tackle with conventional medicines. Traditional Biotherapeutics are becoming more and more common in Human Health due to their selectivity, specificity and flexibility. The cost of development and production of typical monoclonal antibodies all but excludes biotherapeutics from Animal Health. Therapies developed using VHH antibodies retain the positive attributes of antibodies, but at a much lower production cost. This brings biological solutions within the reach of Veterinary Medicine.
A4PBio provide CRO oversight, project management and consultancy services in order to deliver regulatory compliant bioanalysis and bio-logistics solutions to the life science sector. A4PBio offer client-focused solutions in global laboratory selection, through assay development and validation, study sample analysis, data reporting and document review. Combining this with bespoke logistics solutions for the pro-actively managed transport of time and temperature critical biological samples and cell-based therapies. A4PBio's flexible and scalable resources, using considerable Pharmaceutical, Biotechnology and CRO experience, deliver individually built, cost effective, scientifically robust and regulatory compliant outsourcing or consultancy solutions.
As a global life sciences company, Abcam identifies, develops, and distributes high-quality biological reagents and tools that are crucial to research, drug discovery and diagnostics. Working across the industry, the Company supports life scientists to achieve their mission, faster.
Abcam partners with life science organizations to co-create novel binders for use in drug discovery, in vitro diagnostics and therapeutics, driven by the Company’s proprietary discovery platforms and world-leading, antibody expertise.
By constantly innovating its binders and assays, Abcam is helping advance the global understanding of biology and causes of disease, which enables new treatments and improved health. The Company’s pioneering data-sharing approach gives scientists increased confidence in their results by providing validation, user comments and peer-reviewed citations for its 110,000 products.
With twelve sites globally, many of Abcam’s 1,400+ strong team are located in the world’s leading life science research hubs, complementing a global network of services and support.
Abzena is a life science group with headquarters in the UK, and chemistry and manufacturing sites in the US. Abzena’s complimentary services and technologies in chemistry, biology and manufacturing, are applied to the selection, development and manufacture of better biopharmaceuticals.. . Abzena works with most of the top 20 biopharmaceutical companies and academic groups around the world, and has enabled many of them to progress products (ABZENA inside), through to clinical development. Abzena’s teams at the Babraham Research Campus, Cambridge, UK and in San Diego, CA and Bristol, PA in the US are focused on developing better treatments for patients.
Actigen focuses on the development of novel biotherapeutics, specifically antibodies and protein-based drugs. . . Operating globally from its base in Cambridge, UK, Actigen is working with an expanding network of academic, scientific and medical experts to progress a number of development projects.
Adelphi Healthcare Packaging specialises in the supply of primary packaging to the pharmaceutical and biotechnology industries. Adelphi are agents and distributors for some of the world leading manufacturers of healthcare packaging and holds a comprehensive range of glass, plastic and aluminium containers, high precision dispensing systems, various closures including stoppers, crimp seals and screw caps as well as a range of boxes. Adelphi stocks a number of specialist vials and stoppers that are particularly suited to new product development and that provide a highly inert product contact surface. Our particular speciality is helping companies in the very early stages of development to ensure that primary packaging choices are the most appropriate, both commercially and technically for their products.. www.adelphi-hp.com